Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial
- DOI
- 10.1016/s0140-6736(08)61033-8
- Published
- 2008-07
- Container
- The Lancet
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/s0140-6736-08-61033-8,
title = {Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial},
author = {Alexander MM Eggermont and Stefan Suciu and Mario Santinami and Alessandro Testori and Wim HJ Kruit and Jeremy Marsden and Cornelis JA Punt and François Salès and Martin Gore and Rona MacKie and Zvonko Kusic and Reinhard Dummer and Axel Hauschild and Elena Musat and Alain Spatz and Ulrich Keilholz},
year = {2008},
journal = {The Lancet},
doi = {10.1016/s0140-6736(08)61033-8},
url = {https://doi.org/10.1016/s0140-6736(08)61033-8}
}RIS
TY - JOUR TI - Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial AU - Alexander MM Eggermont AU - Stefan Suciu AU - Mario Santinami AU - Alessandro Testori AU - Wim HJ Kruit AU - Jeremy Marsden AU - Cornelis JA Punt AU - François Salès AU - Martin Gore AU - Rona MacKie AU - Zvonko Kusic AU - Reinhard Dummer AU - Axel Hauschild AU - Elena Musat AU - Alain Spatz AU - Ulrich Keilholz PY - 2008 JO - The Lancet DO - 10.1016/s0140-6736(08)61033-8 UR - https://doi.org/10.1016/s0140-6736(08)61033-8 ER -
APA
Eggermont, A. M., Suciu, S., Santinami, M., Testori, A., Kruit, W. H., Marsden, J., Punt, C. J., Salès, F., Gore, M., MacKie, R., Kusic, Z., Dummer, R., Hauschild, A., Musat, E., Spatz, A., & Keilholz, U. (2008). Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial. The Lancet. https://doi.org/10.1016/s0140-6736(08)61033-8
Source records
- crossref · retrieved 2026-09-25T14:26:58.496Z